Skip to main content
. 2024 Sep 9;11:1442275. doi: 10.3389/fcvm.2024.1442275

Table 3.

General characteristics of patients before and after PSM matching.

Parameter Before After
CAD (n = 5,467) Control (n = 41,197) SMD P value CAD (n = 5,430) Control (n = 5,430) SMD P value
Age 67.00 (13.00) 48.00 (17.48) 1.233 <0.001 66.92 (13.00) 67.06 (13.55) 0.011 0.583
Gender = male (%) 2,660 (48.65) 20,414 (49.55) 0.148 0.213 3,028 (55.76) 2,965 (54.60) 0.023 0.224
PP 59.46 (26.73) 64.02 (24.51) 0.178 <0.001 59.56 (26.67) 59.61 (27.21) 0.002 0.923
SBP 124.76 (37.58) 117.93 (31.80) 0.196 <0.001 124.83 (37.47) 125.25 (37.90) 0.011 0.561
DBP 63.44 (21.44) 67.46 (19.28) 0.197 <0.001 63.52 (21.38) 63.61 (21.65) 0.004 0.827
BMI 28.54 (9.68) 28.34 (7.72) 0.023 0.081 28.54 (9.68) 28.73 (8.16) 0.021 0.269
WBC 0.04 (0.55) 0.07 (0.70) 0.041 <0.05 0.04 (0.55) 0.02 (0.40) 0.036 <0.04
RBC 4.29 (1.16) 4.47 (1.13) 0.152 <0.001 4.29 (1.17) 4.29 (1.29) <0.001 >0.999
PLT 221.13 (87.96) 240.99 (85.20) 0.229 <0.001 221.29 (87.91) 221.42 (89.17) 0.002 0.940
Hct 38.71 (10.34) 39.75 (9.94) 0.103 <0.001 38.69 (10.37) 38.62 (11.45) 0.006 0.738
Hb 13.06 (3.52) 13.47 (3.40) 0.118 <0.001 13.06 (3.53) 13.03 (3.88) 0.009 0.673
Basophil 0.04 (0.06) 0.04 (0.06) 0.043 >0.999 0.04 (0.06) 0.04 (0.09) 0.008 >0.999
Eosinophil 0.19 (0.20) 0.17 (0.18) 0.103 <0.001 0.19 (0.19) 0.19 (0.24) 0.011 >0.999
Lymphocyte 1.74 (2.35) 1.88 (2.12) 0.058 <0.001 1.73 (2.27) 1.78 (5.17) 0.013 0.514
Monocyte 0.51 (0.31) 0.47 (0.27) 0.121 <0.001 0.51 (0.30) 0.50 (0.33) 0.014 0.099
CD4 0.43 (22.77) 1.75 (41.21) 0.040 <0.05 0.43 (22.85) 0.03 (2.58) 0.024 0.200
CD8 0.34 (19.22) 1.44 (32.22) 0.041 <0.05 0.34 (19.28) 0.12 (8.83) 0.015 0.445
Fer 1.21 (28.81) 1.15 (16.59) 0.003 0.821 1.22 (28.91) 0.65 (13.94) 0.025 0.191
Hcy 1.14 (4.23) 0.85 (2.89) 0.080 <0.001 1.15 (4.24) 1.05 (3.99) 0.024 0.206
CRP 0.33 (0.92) 0.22 (0.62) 0.143 <0.001 0.32 (0.86) 0.31 (1.01) 0.016 0.579
HDL-C 0.11 (0.38) 0.13 (0.41) 0.039 <0.001 0.11 (0.38) 0.11 (0.39) 0.004 >0.999
LDL-C 1.03 (1.43) 1.19 (1.57) 0.102 <0.001 1.04 (1.43) 1.02 (1.46) 0.008 0.471
TG 1.52 (1.47) 1.46 (1.53) 0.038 <0.001 1.52 (1.47) 1.52 (2.13) 0.004 >0.999
TC 3.85 (2.10) 4.30 (2.05) 0.217 <0.001 3.86 (2.10) 3.86 (2.27) 0.001 >0.999
ApoB 0.27 (0.44) 0.29 (0.46) 0.042 <0.05 0.27 (0.44) 0.27 (0.44) 0.001 >0.999
HbA1c 0.03 (0.45) 0.05 (0.54) 0.038 <0.05 0.03 (0.45) 0.02 (0.36) 0.031 0.201
HBG 0.01 (0.30) 0.02 (0.37) 0.023 0.055 0.01 (0.30) 0.01 (0.26) 0.025 >0.999
Scr 0.68 (15.70) 0.76 (8.34) 0.007 0.558 0.68 (15.75) 0.34 (6.33) 0.028 0.140
eGFR 66.27 (30.13) 89.71 (31.80) 0.757 <0.001 66.51 (30.01) 66.83 (31.84) 0.010 0.590
LVEF (%) 55.2 (8.1) 54.1 (8.3) 0.13 <0.05 55.2 (8.1) 55.3 (8.0) 0.011 0.791
ACEI or ARB (%) 4,897 (89.5) 37,500 (91.0) 0.05 <0.05 4,897 (90.2) 4,885 (89.9) 0.014 0.661
β (%) 3,450 (63.1) 29,031 (70.4) 0.15 <0.05 3,450 (63.6) 3,420 (63.0) 0.010 0.783
Antiplatelet agent 4,905 (89.6) 12,350 (30.1) 1.33 <0.05 4,905 (90.2) 4,885 (89.9) 0.018 0.662

Chi-square test for gender, LVEF, ACEI or ARB, β, Antiplatelet Agent. SMD, Standardized Mean Difference; PP, pulse pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WBC, white blood cell; RBC, red blood cell; PLT, platelets; Hct, hematocrit; Hb, hemoglobin; CD4, CD4 T cell; CD8, CD8 T cell; Fer, ferritin; Hcy, homocysteine; CRP, c-reactive protein; HDL.C, high-density lipoprotein; LDL.C, low-density lipoprotein; TG, triglyceride; TC, total cholesterol; ApoB, apolipoprotein B; HbA1c, glycated hemoglobin; HBG, fasting blood glucose; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; LVEF, Left Ventricular Ejection Fraction; ACEI or ARB, Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker; β, Beta-blockers.